Some consumers who bought insurance under President Barack Obama's health care law have buyer's remorse after realizing that their longtime doctors aren't accepting the new plans.
Industrial blenders mix up smoothies for students in New York while some schools in California are adding salad bars. In Dallas, campus cafeterias use pass-through coolers and warmers to make sure the food is just right before it's served.
Welcome to the virtual house call, the latest twist on telemedicine. It's increasingly getting attention as a way to conveniently diagnose simple maladies, such as whether that runny nose and cough is a cold or the flu.
Danah Boyd has made a name for herself at the research division of Microsoft for painstaking work examining social media, Big Data and the tension between public and private lives, but it's her teens'-eye view of the digital world that sets her apart.
If Mickey Mouse is feeling his age at 86, scientists may have found just the tonic: the blood of younger mice.
Diners could soon see calorie counts on the menus of chain restaurants. But will they be able to get that same clear information at grocery stores, convenience stores, movie theaters or airplanes?
Health officials are worried about recent U.S. measles outbreaks that so far have caused more illnesses than at the same point of any year since 1996.
More companies are starting or expanding wellness programs that aim to reduce their medical costs by improving their employees' health.
Despite recommended limits on codeine use in children, the potent painkiller is prescribed for children in at least half a million emergency room visits each year, a study suggests.
A high-tech screening tool for cervical cancer is facing pushback from more than a dozen patient groups, who warn that the genetic test could displace a simpler, cheaper and more established mainstay of women's health: the Pap smear.
The calorie counting that defined dieting for so long is giving way to other considerations, like the promise of more fiber or natural ingredients
In a north London hospital, scientists are growing noses, ears and blood vessels in a bold attempt to make body parts in the laboratory.
An experimental drug has shown encouraging results in treating advanced breast cancer in an early clinical trial, pharmaceutical giant Pfizer reported Sunday.
A new class of experimental medicines can dramatically lower cholesterol, raising hopes of a fresh option for people who can't tolerate or don't get enough help from Lipitor and other statin drugs that have been used for this for decades.
There's fresh evidence that a lot of young people could be headed for heart trouble. A large study of preteens in Texas found that about one-third of them had borderline or high cholesterol when tested during routine physical exams.